Who Exports Saxagliptin from India — 30 Suppliers Behind a $4.0M Market
India's saxagliptin export market is supplied by 30 active exporters who collectively shipped $4.0M across 258 shipments. MYLAN LABORATORIES LIMITED leads with a 90.0% market share, followed by SAM LIFESTYLE and LOTUS INTERNATIONAL. The top 5 suppliers together control 97.6% of total export value, reflecting a concentrated market structure.
Top Saxagliptin Exporters from India — Ranked by Export Value
MYLAN LABORATORIES LIMITED is the leading saxagliptin exporter from India, holding a 90.0% share of the $4.0M market across 258 shipments from 30 exporters. The top 5 suppliers — MYLAN LABORATORIES LIMITED, SAM LIFESTYLE, LOTUS INTERNATIONAL, SHREE SSD PHARMA PRIVATE LIMITED, HEXA HEALTHCARE PVT LTD — collectively control 97.6% of total export value, indicating a highly concentrated market. Individual shares are: MYLAN LABORATORIES LIMITED (90.0%), SAM LIFESTYLE (6.5%), LOTUS INTERNATIONAL (0.5%), SHREE SSD PHARMA PRIVATE LIMITED (0.4%), HEXA HEALTHCARE PVT LTD (0.3%).
Top Saxagliptin Exporters from India
Ranked by export value · 30 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | MYLAN LABORATORIES LIMITED SAXAGLIPTIN TAB 5MG 30BT US MY, PACKS :SAXAGLIPTIN TAB 2.5MG 30BT US MY, PACKS:SAXAGLIPTIN TAB 5MG 30BT US MY PACKS 21067 | $3.6M | 1 | 90.0% |
| 2 | SAM LIFESTYLE | $259.3K | 1 | 6.5% |
| 3 | LOTUS INTERNATIONAL | $18.9K | 1 | 0.5% |
| 4 | SHREE SSD PHARMA PRIVATE LIMITED | $13.9K | 1 | 0.4% |
| 5 | HEXA HEALTHCARE PVT LTD ONGLYZA 5MG 28 TAB SAXAGLIPTINKOMBIGLYZE XR 5 / 1000MG 28 TAB SAXAGLIPTIN + METFORMINONGLYZA 2.5MG 28 TAB SAXAGLIPTIN | $10.8K | 1 | 0.3% |
| 6 | PLEASANT EXPORTS ONGLYZA 5MG 28 TAB SAXAGLIPTINKOMBIGLYZE XR 5 / 1000MG 28 TAB SAXAGLIPTIN + METFORMINONGLYZA 2.5MG 28 TAB SAXAGLIPTIN | $4.0K | 1 | 0.1% |
| 7 | HEXA HEALTH CARE PRIVATE LIMITED ONGLYZA 5MG 28 TAB SAXAGLIPTINKOMBIGLYZE XR 5 / 1000MG 28 TAB SAXAGLIPTIN + METFORMINONGLYZA 2.5MG 28 TAB SAXAGLIPTIN | $4.0K | 1 | 0.1% |
| 8 | SAVA HEALTHCARE LIMITED ONGLYZA 5MG 28 TAB SAXAGLIPTINKOMBIGLYZE XR 5 / 1000MG 28 TAB SAXAGLIPTIN + METFORMINONGLYZA 2.5MG 28 TAB SAXAGLIPTIN | $3.4K | 1 | 0.1% |
| 9 | LAWRENCE WALTER KOMBIGLYZE XR 5\1000MG (SAXAGLIPTIN-METFKOMBIGLYZE XR 5\1000MG SIZE-28 TABS/PACKSKOMBIGLYZE XR 5\1000MG SAXAGLIPTIN-METF | $2.2K | 2 | 0.1% |
| 10 | RMPL PHARMA LLP | $1.6K | 1 | 0.0% |
| 11 | HEXA HEALTHCARE PVT.LTD., ONGLYZA 5MG 28 TAB SAXAGLIPTINKOMBIGLYZE XR 5 / 1000MG 28 TAB SAXAGLIPTIN + METFORMINONGLYZA 2.5MG 28 TAB SAXAGLIPTIN | $1.1K | 1 | 0.0% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Saxagliptin exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| MYLAN LABORATORIES LIMITED | Warning Letter, November | Yes, April 2025 | Yes | Not verified | Received FDA Warning Letter in November 2019; WHO-GMP certified in April 2025. |
| SAVA HEALTHCARE LIMITED | Not Listed | Yes | Yes | Not verified | WHO-GMP and EU GMP certified; no FDA listing found. |
TransData Nexus reviewed the regulatory standing of 2 leading Saxagliptin exporters from India. 0 hold US FDA facility approvals, 2 maintain WHO-GMP certification, and 2 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Saxagliptin sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Pharma City of India," is a pivotal hub for pharmaceutical manufacturing and research. The city contributes approximately 40% of India's bulk drug production and houses over 2,000 pharmaceutical companies. Notable firms include Dr. Reddy's Laboratories, Aurobindo Pharma, and Natco Pharma. The establishment of Genome Valley, a premier biotech cluster, has further solidified Hyderabad's position in the global pharmaceutical landscape.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations. Gujarat accounts for 33% of India's drug manufacturing and 28% of drug exports. Vadodara is home to Alembic Pharmaceuticals, one of India's oldest pharmaceutical companies, established in 1907. The region's robust infrastructure and skilled workforce have attracted numerous pharmaceutical firms, making it a significant player in both domestic and international markets.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a crucial export gateway for India's pharmaceutical industry. Mumbai, being a major port city, facilitates the export of pharmaceutical products to global markets. The region hosts several pharmaceutical companies that leverage its strategic location and well-developed logistics infrastructure to enhance their export capabilities.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh has emerged as a prominent pharmaceutical cluster, primarily due to favorable tax incentives. The region offers excise duty exemptions and income tax benefits, attracting numerous pharmaceutical manufacturers. This has led to significant investments in the area, bolstering its status as a key player in India's pharmaceutical production landscape.
5Sourcing Recommendations
- Diversify Supplier Base: While MYLAN LABORATORIES LIMITED dominates Saxagliptin exports, consider engaging with other suppliers to mitigate dependency risks.
- Evaluate Regional Capabilities: Assess the manufacturing capabilities of firms in Hyderabad and the Ahmedabad-Vadodara corridor, given their established infrastructure and expertise in bulk drug production and formulations.
- Leverage Export Hubs: Utilize the logistical advantages of the Mumbai-Thane-Raigad region to streamline export processes and reduce lead times.
- Explore Incentive Zones: Investigate potential partnerships with manufacturers in tax incentive zones like Baddi-Nalagarh to capitalize on cost benefits.
By strategically engaging with these pharmaceutical clusters, TransData Nexus can optimize its supply chain for Saxagliptin, ensuring reliability and cost-effectiveness.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Saxagliptin exporters from India
Mylan Laboratories Limited — Mylan Laboratories Limited included in Solactive Shariah Global Markets All Cap Index
On February 19, 2026, Mylan Laboratories Limited was added to the Solactive Shariah Global Markets All Cap Index, reflecting its compliance with Shariah investment principles. - IMPACT: This inclusion may enhance Mylan's market visibility, potentially influencing its Saxagliptin export activities.
Impact: This inclusion may enhance Mylan's market visibility, potentially influencing its Saxagliptin export activities.
Mylan Laboratories Limited — Mylan Laboratories Limited listed among registered laboratories in Haiti
In October 2024, Mylan Laboratories Limited was listed among the registered laboratories in Haiti, indicating its compliance with local regulatory standards. (mspp.gouv.ht) - IMPACT: This registration may facilitate Mylan's Saxagliptin exports to the Haitian market.
Impact: This registration may facilitate Mylan's Saxagliptin exports to the Haitian market.
Mylan Laboratories Limited — Mylan Laboratories Limited listed in Indian Pharmacopoeia Commission's ADR reporting status
In October 2024, Mylan Laboratories Limited was included in the Indian Pharmacopoeia Commission's Adverse Drug Reaction (ADR) reporting status, reflecting its commitment to pharmacovigilance. - IMPACT: This inclusion underscores Mylan's adherence to safety standards, potentially bolstering confidence in its Saxagliptin exports.
Impact: This inclusion underscores Mylan's adherence to safety standards, potentially bolstering confidence in its Saxagliptin exports.
Common Questions — Saxagliptin Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which saxagliptin supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, MYLAN LABORATORIES LIMITED leads with 40 recorded shipments worth $3.6M. SAM LIFESTYLE (10 shipments) and LOTUS INTERNATIONAL (13 shipments) are also established high-volume exporters.
Q How many saxagliptin manufacturers are there in India?
India has 30 active saxagliptin exporters with a combined export market of $4.0M across 258 shipments to 16 countries. The top 5 suppliers hold 97.6% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for saxagliptin from India?
Average FOB unit price: $14.95 per unit, ranging from $0.21 to $1062.27. Average shipment value: $15.4K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 30 verified Indian exporters of Saxagliptin ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 258 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 16 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
258 Verified Shipments
30 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists